idursulfase
Sign in to saveAlso known as Alpha-L-iduronate sulfate sulfatase, Iduronate 2-sulfatase, EC 3.1.6.13, Iduronate-2-sulfatase, IDS, IPR035874
Idursulfase (brand name Elaprase), manufactured by Takeda, is a drug used to treat Hunter syndrome (also called MPS-II). It is a purified form of iduronate-2-sulfatase, a lysosomal enzyme, and is produced by recombinant DNA technology in a human cell line.
~1 min read
Encyclopedic overview
2 sectionsContents
- References
- External links
Idursulfase (brand name Elaprase), manufactured by Takeda, is a drug used to treat Hunter syndrome (also called MPS-II). It is a purified form of iduronate-2-sulfatase, a lysosomal enzyme, and is produced by recombinant DNA technology in a human cell line.
It is one of the most expensive drugs ever produced, costing US$567,412 per patient per year.
Excerpted from Wikipedia’s “idursulfase” article, available under the CC BY-SA 4.0 licence.
Available in 14 languages
via Wikidata sitelinks · CC0